Chromosome 1p status in neuroblastoma correlates with higher expression levels of miRNAs targeting neuronal differentiation pathway.
14q32 locus
1p deletion
MicroRNA
Neuroblastoma
Journal
In vitro cellular & developmental biology. Animal
ISSN: 1543-706X
Titre abrégé: In Vitro Cell Dev Biol Anim
Pays: Germany
ID NLM: 9418515
Informations de publication
Date de publication:
Feb 2023
Feb 2023
Historique:
received:
04
11
2022
accepted:
30
01
2023
medline:
6
4
2023
pubmed:
18
2
2023
entrez:
17
2
2023
Statut:
ppublish
Résumé
Neuroblastoma (NB) is characterized by acquired segmental and numerical chromosome aberrations. Although deletions of distal 1p and 11q are frequent alterations, no candidate tumor suppressor gene residing in these chromosomal sites could be identified so far. In the present study, we detected the genomic imbalances of six neuroblastoma cell lines using the multiplex ligation-dependent probe amplification (MLPA) technique and the microRNA (miRNA) expression profiles of the cell lines by a microarray study. According to MLPA results, we aimed to assess the miRNA expression profiles of the cell lines harboring 11q and 1p deletions. The cell lines with 1p deletions revealed statistically significant higher levels of expression for 29 miRNAs in contrast to the cell lines without 1p deletion in microarray study. We also performed GO enrichment analysis for predicted targets of the differentially expressed miRNAs. According to GO enrichment analysis, miRNAs that showed the high change in expression was associated with neuronal differentiation. We showed that hsa-miR-494, hsa-miR-495, and hsa-miR-543 target most of mRNAs in neuronal differentiation pathway. Although limited to the cell lines, our results highly suggest that NBs with different segmental chromosome abnormalities may have different dysregulated miRNA expression signatures that target the genes involved in neuronal differentiation.
Identifiants
pubmed: 36800078
doi: 10.1007/s11626-023-00750-w
pii: 10.1007/s11626-023-00750-w
doi:
Substances chimiques
MicroRNAs
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
100-108Subventions
Organisme : Dokuz Eylül Üniversitesi
ID : 2009.KB.SAG. 021
Organisme : Dokuz Eylül Üniversitesi
ID : 2005.KB.SAG.077
Informations de copyright
© 2023. The Society for In Vitro Biology.
Références
Ambros IM, Brunner B, Aigner G, Bedwell C, Beiske K, Benard J, Bown N, Combaret V, Couturier J, Defferrari R, Gross N, Jeison M, Lunec J, Marques B, Martinsson T, Mazzocco K, Noguera R, Schleiermacher G, Speleman F, Stallings R, Tonini GP, Tweddle DA, Valent A, Aleš V, Van Roy N, Villamon E, Ziegler A, Preuner S, Drobics M, Ladenstein R, Amann G, Schuit RJL, Potschger U, Ambros PF (2011) A multilocus technique for risk evaluation of patients with neuroblastoma. Clin Cancer Res 17:792–804
pubmed: 21325297
doi: 10.1158/1078-0432.CCR-10-0830
Attiyeh EF, London WB, Mossé YP, Wang Q, Winter C, Khazi D, McGrady PW, Seeger RC, Look AT, Shimada H, Brodeur GM, Cohn SL, Matthay KK, Maris JM (2005) Chromosome 1p and 11q deletions and outcome in neuroblastoma. N Engl J Med 353:2243–2253
pubmed: 16306521
doi: 10.1056/NEJMoa052399
Bader SA, Fasching C, Brodeur GM, Stanbridge EJ (1991) Dissociation of suppression of tumorigenicity and differentiation in vitro effected by transfer of single human chromosomes into human neuroblastoma cells. Cell Growth Differ 2:245–255
pubmed: 1679663
Barbarotto E, Secchiero P, Dasgupta A, Fortina P, Calin GA, Hyslop T (2008) MicroRNAs as new players in the genomic galaxy and disease puzzles. Clin Transl Sci 1:50–56
pubmed: 20443818
pmcid: 5439583
doi: 10.1111/j.1752-8062.2008.00028.x
Beckers A, Van Peer G, Carter DR, Althoff K, Cheung BB, Schulte JH, Mestdag P, Vandesompele J, Marshall GM, De Preter K (2015) MYCN-targeting miRNAs are predominantly downregulated during MYCN-driven neuroblastoma tumor formation. Oncotarget 6:5204–5216
pubmed: 25294817
doi: 10.18632/oncotarget.2477
Betel D, Wilson M, Gabow A, Marks DS, Sander C (2008) The microRNA.org resource: targets and expression. Nucleic Acids Res 36:D149–D153
pubmed: 18158296
doi: 10.1093/nar/gkm995
Biedler JL, Helson L, Spengler BA (1973) Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Can Res 33(11):2643–2652
Bown N (2001) Neuroblastoma tumour genetics: clinical and biological aspects. J Clin Pathol 54:897–910
pubmed: 11729208
pmcid: 1731335
doi: 10.1136/jcp.54.12.897
Bown N, Cotterill S, Lastowska M, O’Neill S, Pearson AD, Plantaz D, Meddeb M, Danglot G, Brinkschmidt C, Christiansen H, Laureys G, Speleman F (1999) Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. NEnglJMed 340:1954–1961
doi: 10.1056/NEJM199906243402504
Brinkschmidt C, Christiansen H, Terpe HJ, Simon R, Boecker W, Lampert F, Stoerkel S (1997) Comparative genomic hybridization (CGH) analysis of neuroblastomas–an important methodological approach in paediatric tumour pathology. J Pathol 181:394–400
pubmed: 9196436
doi: 10.1002/(SICI)1096-9896(199704)181:4<394::AID-PATH800>3.0.CO;2-1
Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rais K, Rassenti L, Kipps T, Negrini M, Bullrich F, Croce CM (2002) Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 99:15524-9
Caron H (1995) Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastoma. Med Pediatr Oncol 24:215–221
pubmed: 7700165
doi: 10.1002/mpo.2950240402
Caron H, Van Sluis P, van Hoeve M, de Kraker J, Bras J, Slater R, Mannens M, Voûte PA, Westerveld A, Versteeg R (1993) Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification. Nat Genet 2:187–190
doi: 10.1038/ng0693-187
Castleberry RP (1997) Neuroblastoma. Eur J Cancer 33:1430–1437
pubmed: 9337686
doi: 10.1016/S0959-8049(97)00308-0
Check E (2007) RNA interference: hitting the on switch. Nature 448:855–858
pubmed: 17713502
doi: 10.1038/448855a
Chédotal A, Kerjan G, Moreau-Fauvarque C (2005) The brain within the tumor: new roles for axon guidance molecules in cancers. Cell Death Differ 12:1044–1056
pubmed: 16015381
doi: 10.1038/sj.cdd.4401707
Chen Y, Stallings RL (2007) Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis. Cancer Res 67:976–983
pubmed: 17283129
doi: 10.1158/0008-5472.CAN-06-3667
Dalmay T, Edwards DR (2006) MicroRNAs and the hallmarks of cancer. Oncogene 25:61706175
doi: 10.1038/sj.onc.1209911
Dalmay T (2008) MicroRNAs and cancer. J Intern Med 263:366–375
pubmed: 18298485
doi: 10.1111/j.1365-2796.2008.01926.x
De Preter K, Vandesompele J, Heimann P, Yigit N, Beckman S, Schramm A, Eggert A, Stallings RL, Benoit Y, Renard M, Paepe AD, Laureys G, Pahlman S, Speleman F (2006) Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes. Genome Biol 7:R84
pubmed: 16989664
pmcid: 1794547
doi: 10.1186/gb-2006-7-9-r84
Dixon-McIver A, East P, Mein CA, Cazier JB, Molloy G, Chaplin T, Andrew Lister T, Young BD, Debernardi S (2008) Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia. PLoS ONE 3:e2141
pubmed: 18478077
pmcid: 2373886
doi: 10.1371/journal.pone.0002141
Edsjö A, Nilsson H, Vandesompele J, Karlsson J, Pattyn F, Culp LA, Speleman F, Påhlman S (2004) Neuroblastoma cells with overexpressed MYCN retain their capacity to undergo neuronal differentiation. Lab Invest 84:406–417
pubmed: 14767491
doi: 10.1038/labinvest.3700061
Fong CT, White PS, Peterson K, Sapienza C, Cavenee WK, Kern SE, Vogelstein B, Cantor AB, Look AT, Brodeur GM (1992) Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas. Cancer Res 52:1780–1785
pubmed: 1551108
Gattolliat CH, Thomas L, Ciafrè SA, Meurice G, Le Teuff G, Job B, Richon C, Combaret V, Dessen P, Valteau-Couanet D, May E, Busson P, Douc-Rasy S, Bénard J (2011) Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma. Br J Cancer 105:1352–1361
pubmed: 21970883
pmcid: 3241557
doi: 10.1038/bjc.2011.388
Genovesi LA, Carter KW, Gottardo NG, Giles KM, Dallas PB (2011) Integrated analysis of miRNA and mRNA expression in childhood medulloblastoma compared with neural stem cells. PLoS ONE 6:e23935
pubmed: 21931624
pmcid: 3170291
doi: 10.1371/journal.pone.0023935
Gennarino VA, D’Angelo G, Dharmalingam G, Fernandez S, Russolillo G, Sanges R, Mutarelli M, Belcastro V, Ballabio A, Verde P, Sardiello M, Banfi S (2012) Identification of microRNAregulated gene networks by expression analysis of target genes. Genome Res 22:1163–1172
pubmed: 22345618
pmcid: 3371699
doi: 10.1101/gr.130435.111
Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ (2008) miRBase: tools for microRNA genomics. Nucleic Acids Res 36:D154–D158
pubmed: 17991681
doi: 10.1093/nar/gkm952
Haller F, von Heydebreck A, Zhang JD, Gunawan B, Langer C, Ramadori G, Wiemann S, Sahin O (2010) Localization- and mutation-dependent microRNA (miRNA) expression signatures in gastrointestinal stromal tumours (GISTs), with a cluster of co-expressed miRNAs located at 14q32.31. J Pathol 220:71–86
pubmed: 19768731
doi: 10.1002/path.2610
Hellmann J, Rommelspacher H, Wernicke C (2009) Long-term ethanol exposure impairs neuronal differentiation of human neuroblastoma cells involving neurotrophin-mediated intracellular signaling and in particular protein kinase C. Alcohol Clin Exp Res 33:538–550
pubmed: 19120063
doi: 10.1111/j.1530-0277.2008.00867.x
Henrich KO, Claas A, Praml C, Benner A, Mollenhauer J, Poustka A, Schwab M, Westermann F (2007) Allelic variants of CAMTA1 and FLJ10737 within a commonly deleted region at 1p36 in neuroblastoma. Eur J Cancer 43:607–616
pubmed: 17222547
doi: 10.1016/j.ejca.2006.09.023
Hill DP, Robertson KA (1997) Characterization of the cholinergic neuronal differentiation of the human neuroblastoma cell line LA-N-5 after treatment with retinoic acid. Brain Res Dev Brain Res 102:53–67
pubmed: 9298234
doi: 10.1016/S0165-3806(97)00076-X
Hinck L (2004) The versatile roles of “axon guidance” cues in tissue morphogenesis. Dev Cell 7:783–793
pubmed: 15572123
doi: 10.1016/j.devcel.2004.11.002
Huber K, Karch N, Ernsberger U, Goridis C, Unsicker K (2005) The role of Phox2B in chromaffin cell development. Dev Biol 279:501–508
pubmed: 15733675
doi: 10.1016/j.ydbio.2005.01.007
Jia L, Cheng L, Raper J (2005) Slit/Robo signaling is necessary to confine early neural crest cells to the ventral migratory pathway in the trunk. Dev Biol 282:411–421
pubmed: 15950606
doi: 10.1016/j.ydbio.2005.03.021
Kawasaki H, Wadhwa R, Taira K (2004) World of small RNAs: from ribozymes to siRNA and miRNA. Differentiation 72:58–64
pubmed: 15066185
doi: 10.1111/j.1432-0436.2004.07202006.x
Lastowska M, Nacheva E, McGuckin A, Curtis A, Grace C, Pearson A, Bown N (1997) Comparative genomic hybridization study of primary neuroblastoma tumors. United Kingdom Children’s Cancer Study Group. Genes Chromosomes Cancer 18:162–169
pubmed: 9071568
doi: 10.1002/(SICI)1098-2264(199703)18:3<162::AID-GCC2>3.0.CO;2-#
Le Douarin N, Dulac C, Dupin E, Cameron-Curry P (1991) Glial cell lineages in the neural crest. Glia 4:175–184
pubmed: 1827777
doi: 10.1002/glia.440040209
Le Douarin NM, Smith J, Le Lièvre CS (1981) From the neural crest to the ganglia of the peripheral nervous system. Annu Rev Physiol 43:653–671
pubmed: 7011203
doi: 10.1146/annurev.ph.43.030181.003253
Lee S, Yoon DS, Paik S, Lee KM, Jang Y, Lee JW (2014) microRNA-495 inhibits chondrogenic differentiation in human mesenchymal stem cells by targeting Sox9. Stem Cells Dev 23:1798–1808
pubmed: 24654627
pmcid: 4103260
doi: 10.1089/scd.2013.0609
Li W, Cogswell CA, LoTurco JJ (1998) Neuronal differentiation of precursors in the neocortical ventricular zone is triggered by BMP. J Neurosci 18:8853–8862
pubmed: 9786991
pmcid: 6793519
doi: 10.1523/JNEUROSCI.18-21-08853.1998
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402–408
pubmed: 11846609
doi: 10.1006/meth.2001.1262
Manohar CF, Furtado MR, Salwen HR, Cohn SL (1993) Hox gene expression in differentiating human neuroblastoma cells. Biochem Mol Biol Int 30:733–741
pubmed: 8104620
Marini P, MacLeod RA, Treuner C, Bruchelt G, Bohm W, Wolburg H, Schweizer P, Girgert R (1999) SiMa, a new neuroblastoma cell line combining poor prognostic cytogenetic markers with high adrenergic differentiation. Cancer Genet Cytogenet 112(2):161–164
pubmed: 10686945
doi: 10.1016/S0165-4608(98)00269-6
Maris JM, Hogarty MD, Bagatell R, Cohn SL (2007) Neuroblastoma. Lancet 369:2106–2120
pubmed: 17586306
doi: 10.1016/S0140-6736(07)60983-0
Matzke M, Aufsatz W, Kanno T, Daxinger L, Papp I, Mette MF, Matzke AJ (2004) Genetic analysis of RNA-mediated transcriptional gene silencing. Biochim Biophys Acta 1677:129–141
pubmed: 15020054
doi: 10.1016/j.bbaexp.2003.10.015
Mavilio F, Simeone A, Boncinelli E, Andrews PW (1988) Activation of four homeobox gene clusters in human embryonal carcinoma cells induced to differentiate by retinoic acid. Differentiation 37:73–79
pubmed: 2898410
doi: 10.1111/j.1432-0436.1988.tb00798.x
Nakagawara A (1998) Molecular basis of spontaneous regression of neuroblastoma: role of neurotrophic signals and genetic abnormalities. Hum Cell 11:115–124
pubmed: 10086274
Nakagawara A, Ohira M (2004) Comprehensive genomics linking between neural development and cancer: neuroblastoma as a model. Cancer Lett 204:213–224
pubmed: 15013220
doi: 10.1016/S0304-3835(03)00457-9
Obernosterer G, Leuschner PJ, Alenius M, Martinez J (2006) Post-transcriptional regulation of microRNA expression. RNA 12:1161–1167
pubmed: 16738409
pmcid: 1484437
doi: 10.1261/rna.2322506
Ohira M, Morohashi A, Inuzuka H, Shishikura T, Kawamoto T, Kageyama H, Nakamura Y, Isogai E, Takayasu H, Sakiyama S, Suzuki Y, Sugano S, Goto T, Sato S, Nakagawara A (2003) Expression profiling and characterization of 4200 genes cloned from primary neuroblastomas: identification of 305 genes differentially expressed between favorable and unfavorable subsets. Oncogene 22:5525–5536
pubmed: 12934113
doi: 10.1038/sj.onc.1206853
Ohira M, Shishikura T, Kawamoto T, Inuzuka H, Morohashi A, Takayasu H, Kageyama H, Takada N, Takahashi M, Sakiyama S, Suzuki Y, Sugano S, Kuma H, Nozawa I, Nakagawara A (2000) Hunting the subset-specific genes of neuroblastoma: expression profiling and differential screening of the full-length-enriched oligo-capping cDNA libraries. Med Pediatr Oncol 35:547–549
pubmed: 11107114
doi: 10.1002/1096-911X(20001201)35:6<547::AID-MPO11>3.0.CO;2-X
Panchision DM, Pickel JM, Studer L, Lee SH, Turner PA, Hazel TG, McKay RD (2001) Sequential actions of BMP receptors control neural precursor cell production and fate. Genes Dev 15:2094–2110
pubmed: 11511541
pmcid: 312756
doi: 10.1101/gad.894701
Pattyn A, Morin X, Cremer H, Goridis C, Brunet JF (1999) The homeobox gene Phox2b is essential for the development of autonomic neural crest derivatives. Nature 399:366–370
pubmed: 10360575
doi: 10.1038/20700
Pietsch T, Gottert E, Meese E, Blin N, Feickert HJ, Riehm H, Kovacs G (1988) Characterization of a continuous cell line (MHH-NB-11) derived from advanced neuroblastoma. Anticancer Res 8(6):1329–1333
pubmed: 3218965
Preis PN, Saya H, Nádasdi L, Hochhaus G, Levin V, Sadée W (1988) Neuronal cell differentiation of human neuroblastoma cells by retinoic acid plus herbimycin A. Cancer Res 48:6530–6534
pubmed: 2846152
Reczko M, Maragkakis M, Alexiou P, Grosse I, Hatzigeorgiou AG (2012) Functional microRNA targets in protein coding sequences. Bioinformatics 28:771–776
pubmed: 22285563
doi: 10.1093/bioinformatics/bts043
Ritke MK, Shah R, Valentine M, Douglass EC, Tereba A (1989) Molecular analysis of chromosome 1 abnormalities in neuroblastoma. Cytogenet Cell Genet 50:84–90
pubmed: 2776489
doi: 10.1159/000132729
Schleiermacher G, Janoueix-Lerosey I, Delattre O (2014) Recent insights into the biology of neuroblastoma. Int J Cancer 135:2249–2261
pubmed: 25124476
doi: 10.1002/ijc.29077
Schlesinger HR, Gerson JM, Moorhead PS, Maguire H, Hummeler K (1976) Establishment and characterization of human neuroblastoma cell lines. Cancer Res 36(9pt.1):3094–3100
pubmed: 10079
Schwab M, Alitalo K, Klempnauer KH, Varmus HE, Bishop JM, Gilbert F, Brodeur G, Goldstein M, Trent J (1983) Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature 305(5931):245–248
pubmed: 6888561
doi: 10.1038/305245a0
Shen PF, Chen XQ, Liao YC, Chen N, Zhou Q, Wei Q, Li X, Wang J, Zeng H (2014) MicroRNA494-3p targets CXCR4 to suppress the proliferation, invasion, and migration of prostate cancer. Prostate 74:756–767
pubmed: 24644030
doi: 10.1002/pros.22795
Shih YY, Lee H, Nakagawara A, Juan HF, Jeng YM, Tsay YG, Lin DT, Hsieh FJ, Pan CY, Hsu WM, Liao YF (2011) Nuclear GRP75 binds retinoic acid receptors to promote neuronal differentiation of neuroblastoma. PLoS ONE 6:e26236
pubmed: 22022577
pmcid: 3194821
doi: 10.1371/journal.pone.0026236
Sidell N (1982) Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro. J Natl Cancer Inst 68:589–596
pubmed: 7040765
Simeone A, Acampora D, Nigro V, Faiella A, D’Esposito M, Stornaiuolo A, Mavilio F, Boncinelli E (1991) Differential regulation by retinoic acid of the homeobox genes of the four HOX loci in human embryonal carcinoma cells. Mech Dev 33:215–227
pubmed: 1677812
doi: 10.1016/0925-4773(91)90029-6
Song L, Liu D, Wang B, He J, Zhang S, Dai Z, Ma X, Wang X (2015) miR-494 suppresses the progression of breast cancer in vitro by targeting CXCR4 through the Wnt/β-catenin signaling pathway. Oncol Rep 34:525–531
pubmed: 25955111
doi: 10.3892/or.2015.3965
Stallings RL, Howard J, Dunlop A, Mullarkey M, McDermott M, Breatnach F, O’Meara A (2003) Are gains of chromosomal regions 7q and 11p important abnormalities in neuroblastoma? Cancer Genet Cytogenet 140:133–137
pubmed: 12645651
doi: 10.1016/S0165-4608(02)00681-7
Tang G, Dong X, Huang X, Huang XJ, Liu H, Wang Y, Ye WC, Shi L (2015) A natural diarylheptanoid promotes neuronal differentiation via activating ERK and PI3K-Akt dependent pathways. Neurosci 303:389–401
doi: 10.1016/j.neuroscience.2015.07.019
Thompson PM, Seifried BA, Kyemba SK, Jensen SJ, Guo C, Maris JM, Brodeur GM, Stram DO, Seeger RC, Gerbing R, Matthay KK, Matise TC, White PS (2001) Loss of heterozygosity for chromosome 14q in neuroblastoma. Med Pediatr Oncol 36:28–31
pubmed: 11464899
doi: 10.1002/1096-911X(20010101)36:1<28::AID-MPO1008>3.0.CO;2-0
Tumilowicz JJ, Nichols WW, Cholon JJ, Greene AE (1970) Definition of a continuous human cell line derived from neuroblastoma. Can Res 30(8):2110–2118
Vandesompele J, Van Roy N, Van Gele M, Laureys G, Ambros P, Heimann P, Devalck C, Schuuring E, Brock P, Otten J, Gyselinck J, De Paepe A, Speleman F (1998) Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridization. Genes Chromosomes Cancer 23:141–152
pubmed: 9739017
doi: 10.1002/(SICI)1098-2264(199810)23:2<141::AID-GCC7>3.0.CO;2-2
Wang X, Yang L, Choi JH, Kitamura E, Chang CS, Ding J, Lee EJ, Cui H, Ding HF (2014) Genome-wide analysis of HOXC9-induced neuronal differentiation of neuroblastoma cells. Genom Data 2:50–52
pubmed: 25013753
pmcid: 4084856
doi: 10.1016/j.gdata.2014.04.002
Yang D, Wang G, Zhu S, Liu O, Wei T, Leng Y, Duan T, Kang J (2014) MiR-495 suppresses mesendoderm differentiation of mouse embryonic stem cells via the direct targeting of Dnmt3a. Stem Cell Research 12:550–561
pubmed: 24530979
doi: 10.1016/j.scr.2014.01.005
Zehir A, Hua LL, Maska EL, Morikawa Y, Cserjesi P (2010) Dicer is required for survival of differentiating neural crest cells. Dev Biol 340:459–467
pubmed: 20144605
pmcid: 2878775
doi: 10.1016/j.ydbio.2010.01.039
Zha Y, Ding E, Yang L, Mao L, Wang X, McCarthy BA, Huang S, Ding HF (2012) Functional dissection of HOXD cluster genes in regulation of neuroblastoma cell proliferation and differentiation. PLoS ONE 7:e40728
pubmed: 22879880
pmcid: 3413684
doi: 10.1371/journal.pone.0040728